Enda Kenny, BSc, PhD

CEO & President

  • 30+ years experience in pharma R&D & regulatory approval
  • Formerly CEO of Rose Pharma AS, VP Stryker Biotech, senior management positions with Inamed (Allergan) & Delta Biotechnology (Albumedix)

Jonathan F. Finn, BA, CFA

Board member

  • Co-founder New Ventures Funds
  • EVP and CIO of Vantage Consulting Group

Michael Forer, BA, LLB

Board member

  • Vice Chairman, ADC Therapeutics
  • Co-founder & Partner Rosetta Capital

Richard Warburg, BSc, PhD

Board member

  • M.D. IP & Licensing for Auven Therapeutics
  • Director of Cristcot, Verigraft & Transparency Life Sciences